POM vs BEAT
Comparison between Pomdoctor Ltd (POM, Company) and HeartBeam Inc (BEAT, Company).
Both POM and BEAT are from the Healthcare sector.
POM vs BEAT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
POM
$31M
Winner
BEAT
$31M
Max Drawdown
POM
98.77%
Winner
BEAT
90.19%
Sharpe Ratio
POM
-0.00
Winner
BEAT
0.16
5Y Beta
POM
0.85
BEAT
N/A
Industry
POM
Pharmaceutical Retailers
BEAT
Health Information Services
P/E Ratio
POM
N/A
BEAT
-1.40
Debt to Equity
POM
N/A
BEAT
0.00%
Free Cash Flow Yield
POM
N/A
BEAT
-44.47%
P/S Ratio
POM
0.09
BEAT
N/A
P/B Ratio
POM
-0.01
BEAT
N/A
POM vs BEAT - Historical Returns
Returns include dividend reinvestment.
1M
POM
-25.37%
Winner
BEAT
-16.87%
3M
POM
-73.52%
Winner
BEAT
-48.45%
6M
POM
-75.95%
Winner
BEAT
-67.05%
1Y
POM
N/A
BEAT
-50.47%
5Y(CAGR)
POM
N/A
BEAT
-32.81%
Max(CAGR)
POM
-99.57%
Winner
BEAT
-32.81%
POM vs BEAT - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | POM | BEAT |
|---|---|---|
| 2026 | -68.86% | -68.81% |
| 2025 | -92.68% | +2.13% |
| 2024 | N/A | -1.29% |
| 2023 | N/A | -48.91% |
| 2022 | N/A | +32.97% |
| 2021 | N/A | -34.33% |
POM vs BEAT Drawdown Comparison
The maximum drawdown for POM was -98.77%, occurring on May 8, 2026. This drawdown has not yet recovered.
The maximum drawdown for BEAT was -90.19%, occurring on Nov 25, 2025. This drawdown has not yet recovered.
The current POM drawdown is -98.33%. The current BEAT drawdown is -87.24%.
| Rank | POM | BEAT |
|---|---|---|
| #1 | -98.77% Nov 6, 2025 - May 8, 2026 | -90.19% Dec 13, 2022 - Nov 25, 2025 |
| #2 | -12.37% Oct 9, 2025 - Oct 28, 2025 | -74.84% Nov 11, 2021 - Oct 6, 2022 |
| #3 | -0.73% Oct 30, 2025 - Nov 3, 2025 | -50.17% Oct 7, 2022 - Dec 8, 2022 |
| #4 | N/A | -5.64% Dec 8, 2022 - Dec 13, 2022 |
Correlation
Correlation between POM and BEAT is 0.09 which considered as a very weak or no correlation - the stocks move independently of each other.
0.09
-101
Select Stocks to Compare
Popular: POM vs SPYBEAT vs SPY
More Comparisons
Compare with similar stocks